Are you Dr. May?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St.
Brigham And Women's Hospital, Division Of Gyn Oncology
Boston, MA 02115Phone+1 617-732-8843
Summary
- Dr. Taymaa May, MD is an obstetrician/gynecologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Faulkner Hospital and is a Clinical Fellow in Obstetrics at Brigham and Women's Hospital.
Education & Training
- Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2010 - 2013
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2004 - 2010
- McGill University Faculty of MedicineClass of 2004
Certifications & Licensure
- MA State Medical License 2010 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Anastomotic diversion rates following integration of indocyanine green fluorescence angiography in cytoreductive surgery for ovarian cancer.Lina Salman, Liat Hogen, Manjula Maganti, Taymaa May
International Journal of Gynecological Cancer. 2024-11-04 - Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcin...Sabrina Piedimonte, Ciara Murray, Eshetu G Atenafu, Marjan Rouzbahman, Stephanie Lheureux
Gynecologic Oncology. 2024-08-01 - 1 citationsPrimary cytoreductive surgery compared with neoadjuvant chemotherapy in patients withmutated advanced high grade serous ovarian cancer: 10 year survival analysis.Soyoun Rachel Kim, Ashna Parbhakar, Xuan Li, Marcus Q Bernardini, Liat Hogen
International Journal of Gynecological Cancer. 2024-06-03
Press Mentions
- HIPEC for Recurrent, Platinum-Sensitive Ovarian Cancer Fails to Improve PFSDecember 3rd, 2024
- Adding HIPEC Boosts Survival in Recurrent Ovarian CancerNovember 14th, 2024